Form 4: Verastem CFO Sells Shares for Tax Obligations
Insider Transaction Report
Verastem's Chief Financial Officer, Daniel Calkins, sold 5,039 shares of common stock at $7.16 per share to cover tax withholdings from restricted stock unit vesting.
Summary
- Daniel Calkins, Chief Financial Officer of Verastem, Inc. (VSTM), reported a sale of common stock.
- The transaction involved the disposition of 5,039 shares of Verastem common stock.
- The shares were sold at a price of $7.16 per share on January 12, 2026.
- The sale was executed to satisfy statutory withholding requirements related to the vesting of restricted stock units.
- Following this transaction, Daniel Calkins beneficially owns 104,719 shares of Verastem common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) pre-planned contract or instruction.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale for tax purposes related to RSU vesting, which is generally considered neutral in terms of market sentiment.
Positives
- The sale was a result of the vesting of restricted stock units, indicating compensation for the Chief Financial Officer.
Negatives
- Daniel Calkins, the Chief Financial Officer, reduced his direct beneficial ownership of Verastem common stock by 5,039 shares.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, but for a routine tax purpose, unlikely to signal a change in management confidence.
- Employees: The vesting of restricted stock units is a form of compensation, which can positively impact executive retention and motivation.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Date of transaction (sale of common stock) |
| 01/14/2026 | Date the Form 4 was signed and filed |
Recommendation
holdThis Form 4 details a routine, pre-planned sale of shares by the CFO to cover tax obligations arising from restricted stock unit vesting. Such transactions are common and typically do not reflect a change in management's outlook on the company's prospects. Therefore, it does not provide sufficient new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.
Keywords
Verastem, VSTM, Insider Transaction, Form 4, Stock Sale, CFO, Restricted Stock Units, Tax Withholding, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.